Kat herine Gat es 5 th year VS TP Leigh Griffit hs Lab American - - PowerPoint PPT Presentation

kat herine gat es 5 th year vs tp leigh griffit hs lab
SMART_READER_LITE
LIVE PREVIEW

Kat herine Gat es 5 th year VS TP Leigh Griffit hs Lab American - - PowerPoint PPT Presentation

Kat herine Gat es 5 th year VS TP Leigh Griffit hs Lab American Heart Associat ion (AHA) est imat es t hat 2.5% of t he populat ion afflict ed by valve disorders 20,000 deat hs annually 100,000 valve replacement s in 2015 alone


slide-1
SLIDE 1

Kat herine Gat es 5th year VS TP Leigh Griffit hs’ Lab

slide-2
SLIDE 2

 American Heart Associat ion (AHA) est imat es t hat 2.5%

  • f t he populat ion afflict ed by valve disorders

 20,000 deat hs annually  100,000 valve replacement s in 2015 alone

slide-3
SLIDE 3

 Bovine Pericardium (BP)

 Glutaraldehyde fixation crosslinks and “ hides”

antigens

 10 year lifespan  ~5 years in j uvenile patients  Calcification and destruction  dysfunction

  • f valve due to residual antigenicity
slide-4
SLIDE 4

 Anything that stimulates an immune response  33 known antigenic proteins in BP  But is it all of them?

Antigen identification is the first step in generating better biomaterials

slide-5
SLIDE 5

 Hypothesis 1: Affinity chromatography can

be used to rapidly identify antigens that human patients have developed as a graft- specific humoral immune response towards glutaraldehyde-fixed BP heart valve replacements.

 Specific aim 1: Apply affinity

chromatography shotgun proteomic antigen identification to determine which BP proteins are xenoantigenic following heart valve replacement.

slide-6
SLIDE 6

 Patient S

election  Protein Extract  Affinity Chromatography  LC-MS / MS  S tatistical Analysis

slide-7
SLIDE 7

Bovine : 39 Mechanical : 44

slide-8
SLIDE 8
slide-9
SLIDE 9

 Hypothesis 2: Human graft-specific immune

responses towards BP heart valve implants are independent of carbohydrate epitopes

 Specific aim 2: Apply affinity

chromatography shotgun proteomic antigen identification process to deglycosylated proteins.

slide-10
SLIDE 10

 Patient S

election  Protein Extract 

Deglycosylation/Alpha-galactosidase 

Affinity Chromatography  LC-MS / MS  S tatistical Analysis

slide-11
SLIDE 11

 Extraction solution does not

interfere with deglycosylation process

 Optimal time is 24 hours of

deglycosylation at 37C for non- denatured proteins

slide-12
SLIDE 12
slide-13
SLIDE 13

 Valve Center at Mayo Clinic

 Prospective collection

 In Vivo study  Heart Transplant Patients

slide-14
SLIDE 14

BIG PICTURE

By knowing what makes a biomaterial antigenic Y

  • u can construct something that

isn’t antigenic

slide-15
SLIDE 15

Questions?